Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast Biotech Investing
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares Psychedelics Investing
COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference Psychedelics Investing
Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland Psychedelics Investing
HempFusion Wellness Inc. Launches Probulin Total Care Immune Probiotic for National Distribution Biotech Investing
Beyond Medical Applauds President Biden's 100 Day Mask Wearing Mandate and Plans to Submit Tenders to US State Governments Biotech Investing
Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity and Reducing Preventable Maternal Deaths in the US Pharmaceutical Investing
Seelos Therapeutics Announces its Inclusion in the First Psychedelic Exchange Traded Fund Psychedelics Investing
Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24 Medical Device Investing
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® in Subjects with Rheumatoid Arthritis Pharmaceutical Investing
